Pozo, David <br/><br/>
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit LPS-stimulated MIP-1alpha production and mRNA expression.  [electronic resource] 

 -  Cytokine  Apr 2002 
 - 35-42 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1043-4666 
<br/><br/><label>Standard No.: </label>10.1006/cyto.2002.1024  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Line<br/>Cells, Cultured<br/>Chemokine CCL3<br/>Chemokine CCL4<br/>Chemokines--metabolism<br/>Cyclic AMP--metabolism<br/>Cyclic AMP-Dependent Protein Kinases--metabolism<br/>Dose-Response Relationship, Drug<br/>Down-Regulation<br/>Lipopolysaccharides--metabolism<br/>Macrophage Inflammatory Proteins--metabolism<br/>Mice<br/>Neuropeptides--metabolism<br/>Pituitary Adenylate Cyclase-Activating Polypeptide<br/>Protein Kinase C--metabolism<br/>RNA, Messenger--metabolism<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Signal Transduction<br/>Time Factors<br/>Vasoactive Intestinal Peptide--metabolism